Back to LGT Group Foundation LGT Group Foundation

NKTRNKTR
Showing 4 of 5 quarters

Position history for LGT Group FoundationLGT Group Foundation's holdings in Nektar Therapeutics

LGT Group Foundation previously held 0 shares of NKTR (Nektar Therapeutics), worth $0 as of 2025-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$14,957

Total Shares Change

-11,246

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$25.76
0
2025-Q1
Unchanged
11,246
0.0%
$7,6470.0%$11.10
0
2024-Q4
Unchanged
11,246
0.0%
$10,4590.0%$14.10
0
2024-Q3
Unchanged
11,246
0.0%
$14,9570.0%$17.55
0

Other major holders of NKTR: BNP PARIBAS FINANCIAL MARKETS, Invesco Ltd., PRIMECAP MANAGEMENT CO/CA/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used